Oppenheimer Downgrades Theravance Biopharma (TBPH) to Perform Mar 5, 2026 10:35AM
B.Riley Downgrades Theravance Biopharma (TBPH) to Neutral Mar 4, 2026 02:11AM
Theravance Biopharma (TBPH) PT Lowered to $21 at BTIG following trial miss Mar 3, 2026 11:49AM
Theravance Biopharma (TBPH) Halted, News Pending Mar 3, 2026 08:26AM
Theravance Biopharma (TBPH) PT Raised to $27 at H.C. Wainwright Mar 2, 2026 06:58AM


Dec 3, 2025 06:03AM Oppenheimer Starts Theravance Biopharma (TBPH) at Outperform
Nov 10, 2025 04:10PM Theravance Biopharma (TBPH) Tops Q3 EPS by 20c, provides guidance
Oct 14, 2025 06:02AM Theravance Biopharma to present YUPELRI data at CHEST 2025 meeting
Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
Sep 12, 2025 02:52AM B.Riley Starts Theravance Biopharma (TBPH) at Buy
Aug 26, 2025 05:21AM BTIG Reiterates Buy Rating on Theravance Biopharma (TBPH)
Aug 13, 2025 06:19AM Theravance Biopharma (TBPH) PT Raised to $13 at Leerink Partners
Aug 12, 2025 04:08PM Theravance Biopharma (TBPH) Tops Q2 EPS by 41c, provides guidance
Jun 26, 2025 04:07PM Theravance Biopharma (TBPH) PT Raised to $25 at BTIG
Jun 26, 2025 06:00AM Theravance Biopharma (TBPH) Announces Approval of YUPELRI by China's NMPA
Jun 3, 2025 05:15AM BTIG Reiterates Buy Rating on Theravance Biopharma (TBPH)
Jun 2, 2025 06:20AM Theravance Biopharma (TBPH) Sells Remaining Royalty Interest in Trelegy Ellipta to GSK (GSK) for $225M
May 8, 2025 04:34PM Theravance Biopharma (TBPH) Misses Q1 EPS by 5c, Beats on Revenue
May 1, 2025 05:11AM Theravance Biopharma (TBPH) PT Raised to $24 at BTIG
Feb 26, 2025 04:34PM Theravance Biopharma (TBPH) Misses Q4 EPS by 11c ; Provides Outlook
Feb 25, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Theravance Biopharma (TBPH)
Nov 13, 2024 09:39AM Leerink Partners Reiterates Market Perform Rating on Theravance Biopharma (TBPH)
Nov 12, 2024 04:11PM Theravance Biopharma (TBPH) Misses Q3 EPS by 3c, provides guidance
Oct 18, 2024 09:02AM Theravance Biopharma (TBPH) Announces Publication of YUPELRI Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
Sep 16, 2024 07:14AM H.C. Wainwright Reiterates Buy Rating on Theravance Biopharma (TBPH)
Aug 6, 2024 09:11AM Theravance Biopharma (TBPH) PT Lowered to $9 at TD Cowen
Aug 6, 2024 06:39AM Theravance Biopharma (TBPH) PT Lowered to $15 at H.C. Wainwright
Aug 5, 2024 04:14PM Theravance Biopharma (TBPH) Misses Q2 EPS by 13c, provides guidance